{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:02:13Z","timestamp":1793678533913,"version":"4.5.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s10815-022-02429-9","type":"journal-article","created":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T21:02:20Z","timestamp":1644786140000},"page":"573-579","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["The use of metformin in women with polycystic ovary syndrome: an updated review"],"prefix":"10.1007","volume":"39","author":[{"given":"Adriana Leal Griz","family":"Notaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6783-307X","authenticated-orcid":false,"given":"Filipe Tenorio Lira","family":"Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"issue":"12","key":"2429_CR1","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag G, et al. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841\u201355.","journal-title":"Hum Reprod"},{"issue":"2","key":"2429_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/humrep\/dep399","volume":"25","author":"WA March","year":"2010","unstructured":"March WA, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25(2):544\u201351.","journal-title":"Hum Reprod"},{"issue":"2","key":"2429_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","volume":"132","author":"R Azziz","year":"2018","unstructured":"Azziz R. Polycystic Ovary syndrome. Obstet Gynecol. 2018;132(2):321\u201336.","journal-title":"Obstet Gynecol"},{"issue":"10","key":"2429_CR4","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/humrep\/des232","volume":"27","author":"BO Yildiz","year":"2012","unstructured":"Yildiz BO, et al. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27(10):3067\u201373.","journal-title":"Hum Reprod"},{"key":"2429_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0015-0282(16)35047-6","volume":"14","author":"JW Goldzieher","year":"1963","unstructured":"Goldzieher JW, Axelrod LR. Clinical and biochemical features of polycystic ovarian disease. Fertil Steril. 1963;14:631\u201353.","journal-title":"Fertil Steril"},{"issue":"1","key":"2429_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"Lizneva D, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106(1):6\u201315.","journal-title":"Fertil Steril"},{"issue":"Suppl 1","key":"2429_CR7","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.fertnstert.2006.03.015","volume":"86","author":"DA Magoffin","year":"2006","unstructured":"Magoffin DA. Ovarian enzyme activities in women with polycystic ovary syndrome. Fertil Steril. 2006;86(Suppl 1):S9-s11.","journal-title":"Fertil Steril"},{"issue":"3","key":"2429_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/humupd\/dmp006","volume":"15","author":"KA Toulis","year":"2009","unstructured":"Toulis KA, et al. Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Hum Reprod Update. 2009;15(3):297\u2013307.","journal-title":"Hum Reprod Update"},{"issue":"6","key":"2429_CR9","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","volume":"20","author":"M Foretz","year":"2014","unstructured":"Foretz M, et al. Metformin: from mechanisms of action to therapies. Cell Metab. 2014;20(6):953\u201366.","journal-title":"Cell Metab"},{"key":"2429_CR10","doi-asserted-by":"publisher","first-page":"110591","DOI":"10.1016\/j.mce.2019.110591","volume":"499","author":"M Di Pietro","year":"2019","unstructured":"Di Pietro M, et al. Metformin has a direct effect on ovarian cells that is dependent on organic cation transporters. Mol Cell Endocrinol. 2019;499:110591.","journal-title":"Mol Cell Endocrinol"},{"issue":"Suppl 2","key":"2429_CR11","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.fertnstert.2005.04.043","volume":"84","author":"B Sonntag","year":"2005","unstructured":"Sonntag B, et al. Metformin alters insulin signaling and viability of human granulosa cells. Fertil Steril. 2005;84(Suppl 2):1173\u20139.","journal-title":"Fertil Steril"},{"key":"2429_CR12","doi-asserted-by":"crossref","unstructured":"Sharpe A et al. (2019) Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews, (12).","DOI":"10.1002\/14651858.CD013505"},{"issue":"6","key":"2429_CR13","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/humupd\/dmz029","volume":"25","author":"R Wang","year":"2019","unstructured":"Wang R, et al. First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis. Hum Reprod Update. 2019;25(6):717\u201332.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"2429_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/humupd\/dms036","volume":"19","author":"ML Misso","year":"2013","unstructured":"Misso ML, et al. Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2013;19(1):2\u201311.","journal-title":"Hum Reprod Update"},{"key":"2429_CR15","doi-asserted-by":"crossref","unstructured":"Abu Hashim H, Foda O, Ghayaty E, Combined metformin-clomiphene in clomiphene-resistant polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Acta Obstet Gynecol Scand, 2015. 94(9): p. 921\u201330.","DOI":"10.1111\/aogs.12673"},{"key":"2429_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1477-7827-12-3","volume":"12","author":"S Palomba","year":"2014","unstructured":"Palomba S, Falbo A, La Sala GB. Metformin and gonadotropins for ovulation induction in patients with polycystic ovary syndrome: a systematic review with meta-analysis of randomized controlled trials. Reprod Biol Endocrinol. 2014;12:3.","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"2429_CR17","doi-asserted-by":"publisher","first-page":"7802","DOI":"10.1038\/s41598-020-64776-w","volume":"10","author":"CH Kim","year":"2020","unstructured":"Kim CH, Chon SJ, Lee SH. Effects of lifestyle modification in polycystic ovary syndrome compared to metformin only or metformin addition: a systematic review and meta-analysis. Sci Rep. 2020;10(1):7802.","journal-title":"Sci Rep"},{"issue":"5","key":"2429_CR18","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmv025","volume":"21","author":"N Naderpoor","year":"2015","unstructured":"Naderpoor N, et al. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Hum Reprod Update. 2015;21(5):560\u201374.","journal-title":"Hum Reprod Update"},{"key":"2429_CR19","doi-asserted-by":"crossref","unstructured":"Tso LO et al. (2020) Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Cochrane Database Syst Rev, 12: p. Cd006105.","DOI":"10.1002\/14651858.CD006105.pub4"},{"key":"2429_CR20","doi-asserted-by":"crossref","unstructured":"Wu Y et al. (2020) Association of metformin with pregnancy outcomes in women with polycystic ovarian syndrome undergoing in vitro fertilization: a systematic review and meta-analysis. JAMA Netw Open, 3(8): p. e2011995.","DOI":"10.1001\/jamanetworkopen.2020.11995"},{"issue":"4","key":"2429_CR21","doi-asserted-by":"publisher","first-page":"E120","DOI":"10.25011\/cim.v39i4.27091","volume":"39","author":"X Tan","year":"2016","unstructured":"Tan X, et al. Effect of metformin treatment during pregnancy on women with PCOS: a systematic review and meta-analysis. Clin Invest Med. 2016;39(4):E120\u201331.","journal-title":"Clin Invest Med"},{"key":"2429_CR22","doi-asserted-by":"crossref","unstructured":"Zeng XL et al. (2016) Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: a meta-analysis. Medicine (Baltimore), 95(36): p. e4526.","DOI":"10.1097\/MD.0000000000004526"},{"key":"2429_CR23","doi-asserted-by":"crossref","unstructured":"Zhao J, Liu X, Zhang W. The Effect of metformin therapy for preventing gestational diabetes mellitus in women with polycystic ovary syndrome: a meta-analysis. Exp Clin Endocrinol Diabetes, 2018.","DOI":"10.1055\/a-0603-3394"},{"key":"2429_CR24","doi-asserted-by":"crossref","unstructured":"Zhuo Z, Wang A, Yu H. Effect of metformin intervention during pregnancy on the gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and meta-analysis. J Diabetes Res, 2014. 2014: p. 381231.","DOI":"10.1155\/2014\/381231"},{"issue":"6","key":"2429_CR25","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1210\/jc.2018-00485","volume":"103","author":"MO Underdal","year":"2018","unstructured":"Underdal MO, et al. Does metformin treatment during pregnancy modify the future metabolic profile in women with PCOS? J Clin Endocrinol Metab. 2018;103(6):2408\u201313.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2429_CR26","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1080\/03007995.2017.1279597","volume":"33","author":"R Patel","year":"2017","unstructured":"Patel R, Shah G. Effect of metformin on clinical, metabolic and endocrine outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials. Curr Med Res Opin. 2017;33(9):1545\u201357.","journal-title":"Curr Med Res Opin"},{"key":"2429_CR27","doi-asserted-by":"crossref","unstructured":"Wang J et al. Effects of metformin treatment on serum levels of C-reactive protein and interleukin-6 in women with polycystic ovary syndrome: a meta-analysis: a PRISMA-compliant article. Medicine (Baltimore), 2017. 96(39): p. e8183.","DOI":"10.1097\/MD.0000000000008183"},{"issue":"2","key":"2429_CR28","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1365-2265.2008.03369.x","volume":"70","author":"S Palomba","year":"2009","unstructured":"Palomba S, et al. Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis. Clin Endocrinol (Oxf). 2009;70(2):311\u201321.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2429_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/er.2008-0030","volume":"30","author":"S Palomba","year":"2009","unstructured":"Palomba S, et al. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev. 2009;30(1):1\u201350.","journal-title":"Endocr Rev"},{"issue":"5","key":"2429_CR30","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/humupd\/dmu022","volume":"20","author":"M Cassina","year":"2014","unstructured":"Cassina M, et al. First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis. Hum Reprod Update. 2014;20(5):656\u201369.","journal-title":"Hum Reprod Update"},{"key":"2429_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.reprotox.2018.05.007","volume":"80","author":"O Diav-Citrin","year":"2018","unstructured":"Diav-Citrin O, et al. In-utero exposure to metformin for type 2 diabetes or polycystic ovary syndrome: a prospective comparative observational study. Reprod Toxicol. 2018;80:85\u201391.","journal-title":"Reprod Toxicol"},{"key":"2429_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.reprotox.2018.07.004","volume":"81","author":"S Scherneck","year":"2018","unstructured":"Scherneck S, et al. Pregnancy outcome after first-trimester exposure to metformin: a prospective cohort study. Reprod Toxicol. 2018;81:79\u201383.","journal-title":"Reprod Toxicol"},{"issue":"2","key":"2429_CR33","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1210\/jc.2017-01191","volume":"103","author":"A Hjorth-Hansen","year":"2018","unstructured":"Hjorth-Hansen A, et al. Fetal Growth and birth anthropometrics in metformin-exposed offspring born to mothers with PCOS. J Clin Endocrinol Metab. 2018;103(2):740\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2429_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S2352-4642(18)30385-7","volume":"3","author":"LGE Hanem","year":"2019","unstructured":"Hanem LGE, et al. Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5\u201310 year follow-up of the PregMet randomised controlled trial. Lancet Child Adolesc Health. 2019;3(3):166\u201374.","journal-title":"Lancet Child Adolesc Health"},{"key":"2429_CR35","doi-asserted-by":"crossref","unstructured":"Rowan JA et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7\u20139 years of age. BMJ Open Diabetes Res Care, 2018. 6(1): p. e000456.","DOI":"10.1136\/bmjdrc-2017-000456"},{"issue":"9","key":"2429_CR36","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602\u201318.","journal-title":"Hum Reprod"},{"issue":"1","key":"2429_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.rbmo.2011.09.017","volume":"24","author":"J Pundir","year":"2012","unstructured":"Pundir J, et al. Meta-analysis of GnRH antagonist protocols: do they reduce the risk of OHSS in PCOS? Reprod Biomed Online. 2012;24(1):6\u201322.","journal-title":"Reprod Biomed Online"},{"key":"2429_CR38","doi-asserted-by":"crossref","unstructured":"Al-Inany HG et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev, 2016. 4: Cd001750.","DOI":"10.1002\/14651858.CD001750.pub4"},{"issue":"3","key":"2429_CR39","first-page":"1126","volume":"86","author":"DJ Jakubowicz","year":"2001","unstructured":"Jakubowicz DJ, et al. Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2001;86(3):1126\u201333.","journal-title":"J Clin Endocrinol Metab"},{"key":"2429_CR40","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.biopha.2018.10.128","volume":"109","author":"F Xiong","year":"2019","unstructured":"Xiong F, et al. Metformin inhibits estradiol and progesterone-induced decidualization of endometrial stromal cells by regulating expression of progesterone receptor, cytokines and matrix metalloproteinases. Biomed Pharmacother. 2019;109:1578\u201385.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2429_CR41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000491086","volume":"84","author":"C Dragamestianos","year":"2019","unstructured":"Dragamestianos C, et al. The Effect of Metformin on the Endometrium of Women with Polycystic Ovary Syndrome. Gynecol Obstet Invest. 2019;84(1):35\u201344.","journal-title":"Gynecol Obstet Invest"},{"key":"2429_CR42","doi-asserted-by":"crossref","unstructured":"Mao W et al. Efficacy and safety of metformin in the treatment of gestational diabetes: a protocol for systematic review and meta-analysis. Medicine (Baltimore), 2021. 100(1): e23954.","DOI":"10.1097\/MD.0000000000023954"},{"key":"2429_CR43","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","volume":"2","author":"R Azziz","year":"2016","unstructured":"Azziz R, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"2429_CR44","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/humupd\/dmq001","volume":"16","author":"LJ Moran","year":"2010","unstructured":"Moran LJ, et al. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010;16(4):347\u201363.","journal-title":"Hum Reprod Update"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-022-02429-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-022-02429-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-022-02429-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T22:06:41Z","timestamp":1649628401000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-022-02429-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["2429"],"URL":"https:\/\/doi.org\/10.1007\/s10815-022-02429-9","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,14]]},"assertion":[{"value":"19 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was exempted from the institutional review board approval, as it was a review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}